Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Net Margin (2016 - 2018)

Armata Pharmaceuticals' Net Margin history spans 6 years, with the latest figure at 2644.51% for Q4 2018.

  • For Q4 2018, Net Margin rose 1429451.0% year-over-year to 2644.51%; the TTM value through Dec 2018 reached 2593.48%, up 1511174.0%, while the annual FY2024 figure was 955.06%, 323236.0% up from the prior year.
  • Net Margin for Q4 2018 was 2644.51% at Armata Pharmaceuticals, up from 523.13% in the prior quarter.
  • Across five years, Net Margin topped out at 13767.96% in Q3 2014 and bottomed at 43181.82% in Q4 2016.
  • The 5-year median for Net Margin is 4563.21% (2016), against an average of 6002.48%.
  • The largest annual shift saw Net Margin plummeted -162086537bps in 2014 before it skyrocketed 3153182bps in 2017.
  • A 5-year view of Net Margin shows it stood at 5652.48% in 2014, then plummeted by -121bps to 1205.59% in 2015, then tumbled by -3482bps to 43181.82% in 2016, then skyrocketed by 73bps to 11650.0% in 2017, then soared by 123bps to 2644.51% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Net Margin are 2644.51% (Q4 2018), 523.13% (Q3 2018), and 11650.0% (Q4 2017).